Champions Oncology Inc (OTCMKTS:CSBR) President Ronnie Morris bought 10,305 shares of the business’s stock in a transaction on Friday, October 14th. The stock was bought at an average price of $1.66 per share, for a total transaction of $17,106.30. Following the purchase, the president now directly owns 1,061,347 shares of the company’s stock, valued at $1,761,836.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Ronnie Morris also recently made the following trade(s):
- On Thursday, October 13th, Ronnie Morris purchased 29,695 shares of Champions Oncology stock. The shares were acquired at an average price of $1.67 per share, for a total transaction of $49,590.65.
- On Monday, October 10th, Ronnie Morris purchased 9,537 shares of Champions Oncology stock. The shares were acquired at an average price of $1.66 per share, for a total transaction of $15,831.42.
- On Tuesday, September 20th, Ronnie Morris purchased 3,000 shares of Champions Oncology stock. The shares were acquired at an average price of $1.58 per share, for a total transaction of $4,740.00.
Shares of Champions Oncology Inc (OTCMKTS:CSBR) traded up 1.82% during midday trading on Monday, hitting $1.68. The stock had a trading volume of 90,156 shares. The stock’s market cap is $18.42 million. Champions Oncology Inc has a one year low of $1.11 and a one year high of $5.46. The firm has a 50 day moving average price of $1.65 and a 200 day moving average price of $2.55.
Champions Oncology (OTCMKTS:CSBR) last posted its earnings results on Friday, September 9th. The company reported ($0.15) earnings per share (EPS) for the quarter. The company earned $3.70 million during the quarter.
About Champions Oncology
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with MarketBeat.com's FREE daily email newsletter.